Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GT Biopharma (GTBP) Preferred Shares (2017 - 2021)

GT Biopharma (GTBP) has disclosed Preferred Shares for 6 consecutive years, with $1000.0 as the latest value for Q3 2021.

  • On a quarterly basis, Preferred Shares fell 96.0% to $1000.0 in Q3 2021 year-over-year; TTM through Sep 2021 was $1000.0, a 96.0% decrease, with the full-year FY2020 number at $2000.0, down 33.33% from a year prior.
  • Preferred Shares was $1000.0 for Q3 2021 at GT Biopharma, down from $2000.0 in the prior quarter.
  • In the past five years, Preferred Shares ranged from a high of $25000.0 in Q3 2020 to a low of $1000.0 in Q4 2017.
  • A 5-year average of $4923.1 and a median of $1000.0 in 2017 define the central range for Preferred Shares.
  • Peak YoY movement for Preferred Shares: soared 2400.0% in 2020, then tumbled 96.0% in 2021.
  • GT Biopharma's Preferred Shares stood at $1000.0 in 2017, then changed by 0.0% to $1000.0 in 2018, then surged by 200.0% to $3000.0 in 2019, then crashed by 33.33% to $2000.0 in 2020, then plummeted by 50.0% to $1000.0 in 2021.
  • Per Business Quant, the three most recent readings for GTBP's Preferred Shares are $1000.0 (Q3 2021), $2000.0 (Q4 2020), and $25000.0 (Q3 2020).